Article
Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
International journal of cancer - 1 Jan 2010
Su Xuefen, Colditz Graham A, Willett Walter C, Collins Laura C, Schnitt Stuart J, Connolly James L, Pollak Michael N, Rosner Bernard, Tamimi Rulla M
Abstract excerpt
Insulin-like growth factor-I (IGF-I) and its major binding protein IGFBP-3 have been implicated in breast carcinogenesis. We examined the associations between genetic variants and circulating levels of IGF-I and IGFBP-3 with proliferative benign breast disease (BBD), a marker of increased breast cancer risk, in the Nurses' Health Study II (NHSII). Participants were 359 pathology-confirmed proliferative BBD cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
